semaglutide and fda prorx issues warning about some compounded versions of for diabetes, weight loss Compounder warned by FDA after – Semaglutide | FDA Orange Book

Week 23: Noticeable fading of post-acne marks and sun-induced discoloration on body

It is either administered orally or through an injection process

Protocol Overview Duration: 28 days (1 vial) Application Schedule: Monday to Friday Daily application on weekdays only Weekend breaks are built into the protocol for balance and consistency Recommended Dose: Applied daily according to the established research protocol to ensure stable and controlled exposure over the 28-day cycle

If at any time the patient develops any severe symptoms (Table 1) after the first dose, administer two additional DuoDote injections i.m

Compounded formulations are not FDA-approved and are only prescribed when medically necessary and after provider evaluation